
Sign up to save your podcasts
Or


Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.
By Fuel Talent5
8181 ratings
Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.

27,147 Listeners

9,516 Listeners

111,970 Listeners

2,647 Listeners

1,430 Listeners